Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2017 | 02-2017 | 11-2016 | 08-2016 | 05-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,066 | -7,991 | -5,939 | -4,226 | -2,426 |
| Depreciation Amortization | 496 | 1,916 | 1,389 | 943 | 468 |
| Income taxes - deferred | N/A | -98 | N/A | N/A | N/A |
| Accounts receivable | 71 | 178 | 143 | 213 | 152 |
| Accounts payable and accrued liabilities | 204 | 484 | 248 | 181 | 273 |
| Other Working Capital | 321 | 854 | 637 | 674 | 144 |
| Other Operating Activity | -250 | -79 | -86 | -84 | -206 |
| Operating Cash Flow | $-1,224 | $-4,737 | $-3,608 | $-2,300 | $-1,594 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 7,066 | 3,945 | 3,042 | 781 |
| PPE Investments | -72 | -1,909 | -1,333 | -812 | -394 |
| Other Investing Activity | 12 | 111 | 87 | 17 | 9 |
| Investing Cash Flow | $-60 | $5,268 | $2,699 | $2,247 | $397 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 5,282 | N/A | N/A | N/A |
| Other Financing Activity | -313 | -14 | -12 | -12 | -10 |
| Financing Cash Flow | $-313 | $5,268 | $-12 | $-12 | $-10 |
| Exchange Rate Effect | -42 | -44 | 7 | -39 | -52 |
| Beginning Cash Position | 7,267 | 2,308 | 2,281 | 2,333 | 2,328 |
| End Cash Position | 5,628 | 8,063 | 1,367 | 2,229 | 1,070 |
| Net Cash Flow | $-1,640 | $5,755 | $-914 | $-104 | $-1,259 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,224 | -4,737 | -3,608 | -2,300 | -1,594 |
| Capital Expenditure | -72 | -1,909 | -1,333 | -812 | -394 |
| Free Cash Flow | -1,296 | -6,646 | -4,941 | -3,112 | -1,987 |